Clinical specialties and research interests include wound healing, autoimmune diseases, and complex medical dermatology.
I am intrigued by the intersection of the cutaneous immune system and wound healing therapies. In particular, I hope to study if mesenchymal stem cells may be isolated from one donor, expanded in culture, and used to treat many unrelated patients without being rejected. This would expand the number of people who may benefit from this novel therapy (developed by Dr. Falanga’s lab).
As mesenchymal stem cells may expand regulatory T cells, I also hope to study the use of mesenchymal stem cells in cutaneous autoimmune diseases.
- University of Washington School of Medicine, MD
- Emory University, BA
- Published on 1/6/2018
Coyne EQ, Lichtman MK, Simons J, Sarkar AK, Rünger TM. In vitro assessment of the broad-spectrum ultraviolet protection of clothing. J Am Acad Dermatol. 2018 Jan 06. PMID: 29317283.
- Published on 10/1/2017
Bae E, White P, Brophy M, Lichtman M, Krathen MS, Mahalingam M. Cutaneous Rosai-Dorfman Disease With Linear Lesions and Monoclonal Gammopathy. Am J Dermatopathol. 2017 Oct; 39(10):776-781. PMID: 28930107.
- Published on 3/15/2017
Asemota E, Markova A, Ho J, Lichtman MK. Disseminated punctate keratoderma: a rare case report and review of the literature. Dermatol Online J. 2017 Mar 15; 23(3). PMID: 28329514.
- Published on 10/15/2016
Abdat R, Markova A, Farraye FA, Lichtman MK. Ustekinumab for treatment of cutaneous Crohn's disease. Dermatol Online J. 2016 Oct 15; 22(10). PMID: 28329588.
- Published on 3/2/2016
Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF-ß) isoforms in wound healing and fibrosis. Wound Repair Regen. 2016 Mar; 24(2):215-22. PMID: 26704519.
- Published on 9/2/2014
Markova A, Kam SA, Miller DD, Lichtman MK. Common cutaneous parasites. Ann Intern Med. 2014 Sep 2; 161(5). PMID: 25178582.
- Published on 3/1/2013
Lichtman MK, Countryman NB. Cell phone-assisted identification of surgery site. Dermatol Surg. 2013 Mar; 39(3 Pt 1):491-2. PMID: 23458254.
- Published on 6/21/2012
Gehad AE, Lichtman MK, Schmults CD, Teague JE, Calarese AW, Jiang Y, Watanabe R, Clark RA. Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas. J Invest Dermatol. 2012 Nov; 132(11):2642-51. PMID: 22718118.
- Published on 1/1/2012
Hanke CW (ed.), Lichtman MK, Bartus B, Tierney E, Leonard A, Levy R, Hsiung S, Strober (associate eds.). The 2012/2013 Dermatology in Review Study Guide. Sanovaworks. 2012.
- Published on 2/4/2004
Klebanoff CA, Finkelstein SE, Surman DR, Lichtman MK, Gattinoni L, Theoret MR, Grewal N, Spiess PJ, Antony PA, Palmer DC, Tagaya Y, Rosenberg SA, Waldmann TA, Restifo NP. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. Proc Natl Acad Sci U S A. 2004 Feb 17; 101(7):1969-74. PMID: 14762166.
View 1 more publications: View full profile at BUMC